Article
The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia
9 Jul 2025
Abstract excerpt
Allogeneic hematopoietic stem cell transplantation (HSCT) has significantly improved the outcome of children with high-risk (HR) acute myeloid leukemia (AML). Implementing allogeneic HSCT depends on numerous factors, including adverse cytogenetics, molecular abnormalities, poor response to first-line treatment, or relapsed or primary refractory disease. In HR AML, allogeneic HSCT is considered to be the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
